Authors:
SAGASTAGOITIA JD
MORILLAS M
MARTINEZ A
LAGE E
PALLARES C
UGARTEMENDIA C
ASIN E
BARRIOS V
JULIA J
SANCHEZ P
CALVO C
GONZALEZ J
PINA C
GARCIABARBAL J
ARNAU C
Citation: Jd. Sagastagoitia et al., IMPROVEMENT IN DIASTOLIC FUNCTION IN HYPE RTENSIVE PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY WITH INHIBITORS OF THE ANGIOTENSIN-CONVERTINGENZYME, Revista Clinica Espanola, 198(1), 1998, pp. 15-22
Authors:
GIMENO C
BORJA J
NAVARRO D
VALDES L
GARCIABARBAL J
GARCIADELOMAS J
Citation: C. Gimeno et al., IN-VITRO INTERACTION BETWEEN OFLOXACIN AND CEFOTAXIME AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA INVOLVED IN SERIOUS INFECTIONS, Chemotherapy, 44(2), 1998, pp. 94-98
Authors:
AZNARSALATTI J
ESCOLAR G
ARNAU C
CARRETERO M
WHITE JG
GARCIABARBAL J
CASTILLO R
ORDINAS A
Citation: J. Aznarsalatti et al., AN INTERMEDIATE-PURITY FACTOR-VIII CONCENTRATE SUPPORTS PLATELET-ADHESION UNDER FLOW CONDITIONS, Haemophilia, 3(1), 1997, pp. 14-20
Citation: Ys. Barbarroja et al., BACTEREMIA IN PATIENTS WITH CLINICAL-CRITERIA OF SEPSIS ENROLLED IN ACLINICAL-TRIAL, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 92-92
Citation: Jb. Villegas et al., USEFULNESS OF AN INVESTIGATORS MEETING PRECIOUS TO THE DEFINITIVE ELABORATION OF A CLINICAL-TRIAL PROTOCOL - ADAPTATION TO THE NECESSITIES OF ASSISTENCIAL MEDICINE, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 108-108
Citation: C. Arnau et al., RECOMMENDATIONS ABOUT NORMALITY OF DATA IN THE EVALUATION OF A CLINICAL, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 109-109
Authors:
PEREZGONZALVO ME
MOSQUERAPESTANA JA
RAMOS D
APILANEZ J
BORJA J
ARNAU C
GARCIABARBAL J
MARINPARDO J
Citation: Me. Perezgonzalvo et al., OFLOXACIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE IN THE TREATMENT OF PATIENTS WITH ACUTE EXACERBATION OF CHRONIC-BRONCHITIS, Clinical therapeutics, 18(3), 1996, pp. 440-447
Authors:
AZNARSALATTI J
ESCOLAR G
ARNAU C
MONTEAGUDO J
VINAS M
WHITE JG
GARCIABARBAL J
ORDINAS A
Citation: J. Aznarsalatti et al., HEMOSTATIC EFFECT OF AN INTERMEDIATE PURITY FACTOR-VIII CONCENTRATE ON VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1171-1171
Citation: J. Borja et al., VANCOMYCIN VERSUS TEICOPLANIN FOR THE TREATMENT OF GRAM-POSITIVE BACTEREMIA IN PATIENTS WITH CANCER, The Journal of infectious diseases, 170(5), 1994, pp. 1344-1344
Citation: Jb. Villegas et J. Garciabarbal, CLINICAL-EVALUATION OF THE EFFECTIVENESS OF DRUG-TREATMENT IN ALZHEIMERS-DISEASE - METHODOLOGICAL CONSIDERATIONS, Revista Clinica Espanola, 193(8), 1993, pp. 445-448